Farrell Michael J.'s Insider Trades & SAST Disclosures
Farrell Michael J.'s most recent trade in Resmed Inc. was a trade of 8,009 ResMed Common Stock Options done . Disclosure was reported to the exchange on March 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Farrell Michael J..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 8,009 | 64,074 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 229.20 per share. | 07 Mar 2025 | 8,009 | 455,472 (0%) | 0% | 229.2 | 1,835,692 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 07 Mar 2025 | 8,009 | 463,481 (0%) | 0% | 101.6 | 814,035 | ResMed Common Stock |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 12,295 | 12,295 | - | - | Service-Based Restricted Stock Unit | |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 64,068 | 156,397 (0%) | 0% | 0 | Common Stock | |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.08 per share. | 22 Feb 2025 | 27,794 | 128,603 (0%) | 0% | 27.1 | 752,662 | Common Stock |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 16,017 | 0 | - | - | Service-Based Restricted Stock Units | |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 16,017 | 99,312 (0%) | 0% | 0 | Common Stock | |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.08 per share. | 22 Feb 2025 | 6,983 | 92,329 (0%) | 0% | 27.1 | 189,100 | Common Stock |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 4,176 | 85,202 (0%) | 0% | 0 | Common Stock | |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 4,176 | 8,481 | - | - | Service-Based Restricted Stock Units | |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.69 per share. | 15 Feb 2025 | 1,907 | 83,295 (0%) | 0% | 26.7 | 50,898 | Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 236.77 per share. | 07 Feb 2025 | 8,009 | 455,472 (0%) | 0% | 236.8 | 1,896,307 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 07 Feb 2025 | 8,009 | 463,481 (0%) | 0% | 101.6 | 814,035 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 8,009 | 72,083 | - | - | ResMed Common Stock Options | |
| Zimmer Biomet Holdings Inc | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 307 | 15,259 | - | - | Phantom Stock Units | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2024 | 33,036 | 33,036 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 249.66 per share. | 25 Nov 2024 | 2,000 | 0 (0%) | 0% | 249.7 | 499,330 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2024 | 2,000 | 2,090 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2024 | 2,000 | 2,000 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 246.26 per share. | 07 Nov 2024 | 14,683 | 464,254 (0%) | 0% | 246.3 | 3,615,821 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.98 per share. | 07 Nov 2024 | 14,683 | 478,937 (0%) | 0% | 85.0 | 1,247,761 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2024 | 14,683 | 0 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 252.45 per share. | 07 Nov 2024 | 3,452 | 455,472 (0%) | 0% | 252.4 | 871,443 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 252.41 per share. | 07 Nov 2024 | 3,101 | 461,152 (0%) | 0% | 252.4 | 782,725 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 252.48 per share. | 07 Nov 2024 | 2,226 | 458,925 (0%) | 0% | 252.5 | 562,016 | ResMed Common Stock |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Sale of securities on an exchange or to another person at price $ 28.99 per share. | 06 Nov 2024 | 25,900 | 81,026 (0%) | 0% | 29.0 | 750,841 | Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 231.91 per share. | 07 Oct 2024 | 14,683 | 464,169 (0%) | 0% | 231.9 | 3,405,206 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.98 per share. | 07 Oct 2024 | 14,683 | 478,852 (0%) | 0% | 85.0 | 1,247,761 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 14,683 | 14,683 | - | - | ResMed Common Stock Options | |
| Zimmer Biomet Holdings Inc | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 301 | 14,918 | - | - | Phantom Stock Units | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 248.38 per share. | 09 Sep 2024 | 14,683 | 464,169 (0%) | 0% | 248.4 | 3,646,950 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2024 | 14,683 | 29,366 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.98 per share. | 09 Sep 2024 | 14,683 | 478,852 (0%) | 0% | 85.0 | 1,247,761 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2024 | 19,272 | 460,071 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2024 | 4,098 | 464,169 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2024 | 14,683 | 44,049 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 214.25 per share. | 07 Aug 2024 | 14,683 | 440,799 (0%) | 0% | 214.3 | 3,145,905 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.98 per share. | 07 Aug 2024 | 14,683 | 455,482 (0%) | 0% | 85.0 | 1,247,761 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2024 | 14,683 | 58,732 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 192.97 per share. | 08 Jul 2024 | 14,683 | 440,799 (0%) | 0% | 193.0 | 2,833,330 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.98 per share. | 08 Jul 2024 | 14,683 | 455,482 (0%) | 0% | 85.0 | 1,247,761 | ResMed Common Stock |
| Zimmer Biomet Holdings Inc | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 299 | 14,586 | - | - | Phantom Stock Units | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 14,683 | 73,415 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.98 per share. | 07 Jun 2024 | 14,683 | 455,482 (0%) | 0% | 85.0 | 1,247,761 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 211.66 per share. | 07 Jun 2024 | 14,683 | 440,799 (0%) | 0% | 211.7 | 3,107,739 | ResMed Common Stock |
| Zimmer Biomet Holdings Inc | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 1,068 | 10,831 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 616 | 14,286 | - | - | Phantom Stock Units | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 216.50 per share. | 07 May 2024 | 14,683 | 440,752 (0%) | 0% | 216.5 | 3,178,815 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 13,507 | 88,098 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.98 per share. | 07 May 2024 | 13,507 | 455,435 (0%) | 0% | 85.0 | 1,147,825 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.98 per share. | 07 May 2024 | 1,176 | 441,928 (0%) | 0% | 85.0 | 99,936 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 1,176 | 101,605 | - | - | ResMed Common Stock Options | |
| Federated Hermes Inc - Ord... | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 2,400 | 52,050 (0%) | 0% | 0 | Class B Common Stock | |
| Zimmer Biomet Holdings Inc | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 244 | 13,643 | - | - | Phantom Stock Units | |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Sale of securities on an exchange or to another person at price $ 27.29 per share. | 12 Mar 2024 | 28,080 | 106,926 (0%) | 0% | 27.3 | 766,303 | Common Stock |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2024 | 68,030 | 164,734 (0%) | 0% | 0 | Common Stock | |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.40 per share. | 24 Feb 2024 | 29,728 | 135,006 (0%) | 0% | 26.4 | 784,819 | Common Stock |
| Graphic Packaging Holding Co | Michael Farrell J. | EVP, Mills Division | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2024 | 17,007 | 104,119 (0%) | 0% | 0 | Common Stock | |
| Graphic Packaging Holding Co | Michael Farrell J. | EVP, Mills Division | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2024 | 17,007 | 0 | - | - | Service-Based Restricted Stock Units | |
| Graphic Packaging Holding Co | Farrell Michael J. | EVP, Mills Division | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.40 per share. | 24 Feb 2024 | 7,415 | 96,704 (0%) | 0% | 26.4 | 195,756 | Common Stock |
| Graphic Packaging Holding Co | Farrell J. Michael | EVP, Mills Division | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 12,656 | 12,656 | - | - | Service-Based Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | J. Farrell Michael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 266 | 13,373 | - | - | Phantom Stock Units | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2023 | 55,468 | 55,468 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 16 Nov 2023 | 3,462 | 444,448 (0%) | 0% | 57.8 | 199,965 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2023 | 3,462 | 0 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 149.00 per share. | 16 Nov 2023 | 2,352 | 440,752 (0%) | 0% | 149.0 | 350,445 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 148.90 per share. | 16 Nov 2023 | 1,343 | 443,105 (0%) | 0% | 148.9 | 199,973 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2023 | 5,678 | 3,462 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 152.04 per share. | 15 Nov 2023 | 5,678 | 440,986 (0%) | 0% | 152.0 | 863,281 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 15 Nov 2023 | 5,678 | 446,664 (0%) | 0% | 57.8 | 327,961 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.63 per share. | 13 Nov 2023 | 3,232 | 446,205 (0%) | 0% | 143.6 | 464,217 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.64 per share. | 13 Nov 2023 | 3,037 | 443,167 (0%) | 0% | 143.6 | 436,243 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.62 per share. | 13 Nov 2023 | 2,181 | 440,986 (0%) | 0% | 143.6 | 313,233 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2023 | 5,675 | 9,140 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 140.70 per share. | 16 Oct 2023 | 5,675 | 449,360 (0%) | 0% | 140.7 | 798,464 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 16 Oct 2023 | 5,675 | 455,035 (0%) | 0% | 57.8 | 327,788 | ResMed Common Stock |
| Zimmer Biomet Holdings Inc | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 320 | 13,110 | - | - | Phantom Stock Units | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2023 | 5,675 | 14,815 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 146.35 per share. | 15 Sep 2023 | 5,675 | 449,360 (0%) | 0% | 146.3 | 830,514 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 15 Sep 2023 | 5,675 | 455,035 (0%) | 0% | 57.8 | 327,788 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2023 | 12,430 | 449,360 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 5,675 | 20,490 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 183.20 per share. | 15 Aug 2023 | 5,675 | 436,930 (0%) | 0% | 183.2 | 1,039,647 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 15 Aug 2023 | 5,675 | 442,605 (0%) | 0% | 57.8 | 327,788 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 5,675 | 26,165 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 221.27 per share. | 17 Jul 2023 | 5,675 | 436,930 (0%) | 0% | 221.3 | 1,255,686 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 17 Jul 2023 | 5,675 | 442,605 (0%) | 0% | 57.8 | 327,788 | ResMed Common Stock |
| Zimmer Biomet Holdings Inc | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 247 | 12,767 | - | - | Phantom Stock Units | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 217.39 per share. | 15 Jun 2023 | 5,675 | 436,930 (0%) | 0% | 217.4 | 1,233,716 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 5,675 | 31,840 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 15 Jun 2023 | 5,675 | 442,605 (0%) | 0% | 57.8 | 327,788 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 5,675 | 37,515 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 232.10 per share. | 15 May 2023 | 5,675 | 436,930 (0%) | 0% | 232.1 | 1,317,191 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 15 May 2023 | 5,675 | 442,605 (0%) | 0% | 57.8 | 327,788 | ResMed Common Stock |
| Zimmer Biomet Holdings Inc | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 950 | 9,762 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings Inc | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 500 | 12,520 | - | - | Phantom Stock Units | |
| Federated Hermes Inc - Ord... | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 2,400 | 49,650 (0%) | 0% | 0 | Class B Common Stock | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 5,675 | 43,190 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 224.23 per share. | 17 Apr 2023 | 5,675 | 436,900 (0%) | 0% | 224.2 | 1,272,526 | ResMed Common Stock |
| Resmed Inc. | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 17 Apr 2023 | 5,675 | 442,575 (0%) | 0% | 57.8 | 327,788 | ResMed Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges